Gene · 406962
Papers2,086
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,086
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum resistin and the risk for hepatocellular carcinoma in diabetic patients. | World J Gastroenterol | 2023 | 37545641 | PubTator, text mining | PubMed |
| Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art. | Cancer Cell Int | 2023 | 37543612 | PubTator, text mining | PubMed |
| Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma. | Front Pharmacol | 2023 | 37521469 | PubTator, text mining | PubMed |
| LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer. | Front Genet | 2023 | 37519886 | PubTator, text mining | PubMed |
| MicroRNAs as a Potential Biomarker in the Diagnosis of Cardiovascular Diseases. | Medicina (Kaunas) | 2023 | 37512140 | PubTator, text mining | PubMed |
| MicroRNAs in Juvenile Idiopathic Arthritis: State of the Art and Future Perspectives. | Biology (Basel) | 2023 | 37508421 | PubTator, text mining | PubMed |
| MiR-223-3p affects the proliferation and apoptosis of HCAECs in Kawasaki disease by regulating the expression of FOXP3. | Immun Inflamm Dis | 2023 | 37506144 | PubTator, text mining | PubMed |
| Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492716 | PubTator, text mining | PubMed |
| miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM. | Aging (Albany NY) | 2023 | 37477531 | PubTator, text mining | PubMed |
| Extracellular vesicles in atherosclerosis and vascular calcification: the versatile non-coding RNAs from endothelial cells and vascular smooth muscle cells. | Front Med (Lausanne) | 2023 | 37469665 | PubTator, text mining | PubMed |
| Sparse Independence Component Analysis for Competitive Endogenous RNA Co-Module Identification in Liver Hepatocellular Carcinoma. | IEEE J Transl Eng Health Med | 2023 | 37465460 | PubTator, text mining | PubMed |
| Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37457718 | PubTator, text mining | PubMed |
| Expression profile of LncRNA ANRIL, miR-186, miR-181a, and MTMR-3 in patients with preeclampsia. | Noncoding RNA Res | 2023 | 37456780 | PubTator, text mining | PubMed |
| Role of salivary miRNAs in the diagnosis of gastrointestinal disorders: a mini-review of available evidence. | Front Genet | 2023 | 37456668 | PubTator, text mining | PubMed |
| circRPS19 affects HK2‑mediated aerobic glycolysis and cell viability via the miR‑125a‑5p/USP7 pathway in gastric cancer. | Int J Oncol | 2023 | 37449524 | PubTator, text mining | PubMed |
| microRNA Expression of Renal Proximal Tubular Epithelial Cells and Their Extracellular Vesicles in an Inflammatory Microenvironment In Vitro. | Int J Mol Sci | 2023 | 37446246 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms. | Int J Mol Sci | 2023 | 37445850 | PubTator, text mining | PubMed |
| Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions. | Cancers (Basel) | 2023 | 37444616 | PubTator, text mining | PubMed |
| Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition. | Cancers (Basel) | 2023 | 37444447 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406962/papers?page=8